{"title": "Posible encefalopat\u00eda t\u00f3xica no alcoh\u00f3lica por vacuna Covid en paciente con hepatopat\u00eda", "author": "Jos\u00e9 Mar\u00eda Gonz\u00e1lez San Jos\u00e9", "url": null, "hostname": null, "description": "Since the beginning of the inoculations of experimental gene therapies called \"Covid vaccines\", the presence of multisystemic symptoms of different types and severities has been observed. We report the case of encephalopathy in a patient awaiting liver transplantation, at the time not affiliated with an acute or chronic, alcoholic or viral digestive process, and possibly caused by a brain inflammatory process mediated by the toxic capacity of nanoparticle excipients. lipids present in Covid vaccines (mRNA type) that have the property of crossing the blood-brain barrier (BBB). The patient was previously informed of the risk of encephalopathy by the Primary Care nursing staff. Nursing has a fundamental role in prevention and tracking adverse effects in the short, medium and long term.", "sitename": "Evidentia", "date": "2023-02-06", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Posible encefalopat\u00eda t\u00f3xica no alcoh\u00f3lica por vacuna Covid en paciente con hepatopat\u00eda\nPossible non-alcoholic toxic encephalopathy due to Covid vaccine in a patient with liver disease\nResumen\nAbstract\nBibliograf\u00eda\n1. Weissenborn K. Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles. Drugs. 2019. 79(Suppl 1), 5\u20139. https://doi.org/10.1007/s40265-018-1018-z\n2. Medline Plus. National Library of Medicine (NIH \u2013 NLM) U.S. Department of Health and Human Services. ADAM Health Solutions. 1997-2022. Encefalopat\u00eda Hep\u00e1tica. (Sitio Web). https://medlineplus.gov/spanish/ency/article/000302.htm.\n3. Bosch B, van der Zee R, de Haan C, & Rottier P. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. Journal of Virology 2003; 77(16). https://doi.org/10.1128/jvi.77.16.8801-8811.2003\n4. Gonz\u00e1lez San Jos\u00e9, Jos\u00e9 Mar\u00eda. Necrosis de pie por isquemia arterial aguda tras vacuna Covid. Evidentia. 2022; 29: e13916. http://ciberindex.com/c/ev/e13916\n5. Romero de San P\u00edo, E., Romero de San P\u00edo, M., & Gonz\u00e1lez S\u00e1nchez, S. Derecho al honor, al prestigio y a la salvaguarda de la dignidad profesional en enfermer\u00eda. Revista Ene De Enfermer\u00eda. 2016; 10(1). http://ene-enfermeria.org/ojs/index.php/ENE/article/view/607\n6. Organizaci\u00f3n Mundial de la Salud. Centro Internacional de monitorizaci\u00f3n de medicamentos. Centro de monitorizaci\u00f3n de Uppsala. Datos de Efectos Adversos para \u201cCovid-19 vaccine\u201d. (VIGIACCESS) https://www.vigiaccess.org/\n7. Perez, Jean Claude, Moret-Chalmin, Claude, Montagnier, L. Towards the emergence of a new form of the neurodegenerative Creutzfeldt-Jakob disease: Twenty-six cases of CJD declared a few days after a COVID-19 \u201cvaccine\u201d Jab. 2021. Disponible en: https://canadahealthalliance.org/wp-content/uploads/2022/06/V2CJDPerezMoretMontagnierRIP2022REFERENCEARTICLE.pdf\n8. National Vaccine Information Center. Creutzfeldt-Jakob disease. MedAlert.org (Sitio Web). 2022. https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&EVENTS=ON&SYMPTOMS=Creutzfeldt-Jakob+disease+%2810011384%29&VAX=COVID19\n9. Lazarus R, Klompas M, & Berstein S. Electronic Support for Public Health\u2013Vaccine Adverse Event Reporting System (ESP: VAERS). U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality (AHRQ). 2010 (Rockvi-lle - EEUU). https://digital.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarus-final-report-2011.pdf\n10. Vaccine Adverse Event Reporting System. (VAERS, Ed.). OPENVAERS. https://openvaers.com/\n11. European Mortality Monitoring activity. (EUROMOMO). https://www.euromomo.eu/\n12. Desfargues, S., Ciuffi, A. & Witzany, G. Viral Integration and Consequences on Host Gene Expression. Viruses: Essential Agents of Life. 2012; 147-175. https://doi.org/10.1007/978-94-007-4899-6_7\n13. Zhang, L., Richards, A., Barrasa, M., Hughes, S., Young, R., & Jaenisch, R. Reverse-transcribed SARS-CoV-2 RNA can inte-grate into the genome of cultured human cells and can be expressed in patient-derived tissues. PNAS. 2021; 118(21). https://doi.org/10.1073/pnas.2105968118\n14. Pastrian-Soto G. Presencia y Expresi\u00f3n del Receptor ACE2 (Target de SARS-CoV-2) en Tejidos Humanos y Cavidad Oral. Posibles Rutas de Infecci\u00f3n en \u00d3rganos Orales. International journal of odontostomatology 2020; 14(4). http://dx.doi.org/10.4067/S0718-381X2020000400501\n15. Sun S.-H, Chen Q, Gu H-J, Yang G, Wang Y-X, Huang X-Y et al. A Mouse Model of SARS-CoV-2 Infection and Pathogene-sis. Cell Host & Microbe 2020; 28(1), 124-133. https://doi.org/10.1016/j.chom.2020.05.020\n16. Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong J-C, Turner A, et al. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circula-tion Research 2020; 126(10), 1456-1474. https://doi.org/10.1161/CIRCRESAHA.120.317015\n17. Li M-Y, Li L, Zhang Y, Wang X-S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious Disease of Poverty 2020; 9(1), 45. https://doi.org/10.1186/s40249-020-00662-x\n18. ECHELON Bioscience. Lipid Nanoparticles for RNA Delivery. Disponible en https://www.echelon-inc.com/lipid-nanoparticles-for-rna-delivery/\n19. National Center for Biotechnology Information (NCBI). National Institute of Health (NIH). PUBCHEM., SM-102. de Na-tional Center for Biotechnology Information (NCBI): Disponible en https://www.ncbi.nlm.nih.gov/pcsubstance/?term=sm-102\n20. National Center for Biotechnology Information (NCBI). National Institute of Health (NIH). PUBCHEM., ALC-0315. de Na-tional Center for Biotechnology Information (NCBI): Disponible en https://www.ncbi.nlm.nih.gov/pcsubstance/?term=alc-0315\n21. National Center for Biotechnology Information (NCBI). National Institute of Health (NIH). PUBCHEM., ALC-0159. de Na-tional Center for Biotechnology Information (NCBI): Disponible en https://www.ncbi.nlm.nih.gov/pcsubstance/?term=alc-0159\n22. Wang, Y.-J., Wang, J., Hao, D.-L., Yue, Q.-X., Xie, R., De, G.-J., . . . Chen, Y.-J. Preparation of docetaxel-loaded nanomicelles and their anti-Lewis lung cancer effect in vitro. Zhongguo Zhong Yao Za Zhi. 2019. 44(11), 2251-2259. https://doi.org/10.19540/j.cnki.cjcmm.20190326.305\n23. Sharpe, M., Easthope, S., Keating, G., & Lamb, H. Polyethylene glycol-liposomal doxorubicin: a review of its use in the man-agement of solid and haematological malignancies and AIDS-related Kaposi's sarcoma. Drugs 2002; 62(14), 2089-126. https://doi.org/10.2165/00003495-200262140-00012\n24. Lim, W., Rajinikanth, P., Mallikarjun, C., & Kang, Y. Formulation and delivery of itraconazole to the brain using a nanolipid carrier system. Int J Nanomedicine 2014; 9, 2117-2126. https://doi.org/10.2147/IJN.S57565\n25. Radice, A., Fassio, F., Meucci, E., Iorno, M., & Maccia, D. Potential culprits for immediate hypersensitivity reactions to BNT162b2 mRNA COVID-19 vaccine: not just PEG. (A. A. Ospedalieri, Ed.) Eur Ann Allergy Clin Immunol 2021; 53(5), 240-242. https://doi.org/10.23822/EurAnnACI.1764-1489.214\n26. Caballero, M., & Quirce, S. Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Cur-rently Authorized COVID-19 Vaccines. J Investig Allergol Clin Immunol 2021; 31(1), 92-93. https://doi.org/10.18176/jiaci.0667\n27. Rojas-P\u00e9rez-Ezquerra, P., Crespo Quir\u00f3s, J., Tornero Molina, P., Baeza Ochoa de Oc\u00e1riz, M., & Zubeldia Ortu\u00f1o, J. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients. J Investig Allergol Clin Immunol 2021; 31(2), 180-181. https://doi.org/10.18176/jiaci.0683\n28. Pall ML. Explaining \u201cUnexplained Illneses\u201d. New York: Informa Healthcare; (Pag 49-68). 2009.\n29. Paredes Rizo M\u00aa Luisa. Sensibilidad Qu\u00edmica M\u00faltiple: an\u00e1lisis de un caso registrado en un Hospital de referencia. Med. segur. trab. 2018; 64 (251): 217-240. http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0465-546X2018000200217&lng=es\n30. Glassford JAG. The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Front Physiol. 2017; 8(88). https://doi.org/10.3389/fphys.2017.00088\n- Resumen visto - 825 veces\n- PDF descargado - 40 veces", "language": null, "image": null, "pagetype": null, "links": ["#pkp_content_main", "#pkp_content_nav", "#pkp_content_footer", "http://fundacionindex.com", "http://ciberindex.com/index.php/ev/index", "http://ciberindex.com/index.php/ev/issue/current", "http://ciberindex.com/index.php/ev/issue/archive", "http://ciberindex.com/index.php/ev/about", "http://ciberindex.com/index.php/ev/autores", "http://www.index-f.com/hemeroteca.php", "http://ciberindex.com/index.php/ev/about", "http://www.index-f.com/new/cuiden/", "http://www.index-f.com/cuidenplus/cantaridaesmas.php", "http://www.index-f.com/b_cantarida/formulario.php", "http://ciberindex.com/index.php/ev/search/search", "#", "http://fundacionindex.com/bootstrap/pages/login.php?url=http://ciberindex.com/index.php/ev/article/view/e14291&plataforma=bc7ba35ef4692635279c76df5f022f75", "#", "http://ciberindex.com/index.php/ev/user/setLocale/en_US?source=%2Findex.php%2Fev%2Farticle%2Fview%2Fe14291", "http://ciberindex.com/index.php/ev/user/setLocale/pt_PT?source=%2Findex.php%2Fev%2Farticle%2Fview%2Fe14291", "http://ciberindex.com/index.php/ev/index", "http://ciberindex.com/index.php/ev/issue/archive", "http://ciberindex.com/index.php/ev/issue/view/294", "mailto:jmgonzalezs@sescam.jccm.es", "http://fundacionindex.com/bootstrap/pages/login.php?url=http://ciberindex.com/index.php/ev/article/view/e14291/e14291&plataforma=bc7ba35ef4692635279c76df5f022f75", "#comentarios", "http://cantarida.fundacionindex.com/busqueda.php?buscador=-&p1=Vacuna Covid&p2=Nanopart\u00edculas Lip\u00eddicas (LNP)&operador=AND", "http://ciberindex.com/index.php/ev/citationstylelanguage/get/acm-sig-proceedings?submissionId=5582", "http://ciberindex.com/index.php/ev/citationstylelanguage/get/acs-nano?submissionId=5582", "http://ciberindex.com/index.php/ev/citationstylelanguage/get/apa?submissionId=5582", "http://ciberindex.com/index.php/ev/citationstylelanguage/get/associacao-brasileira-de-normas-tecnicas?submissionId=5582", "http://ciberindex.com/index.php/ev/citationstylelanguage/get/chicago-author-date?submissionId=5582", "http://ciberindex.com/index.php/ev/citationstylelanguage/get/harvard-cite-them-right?submissionId=5582", "http://ciberindex.com/index.php/ev/citationstylelanguage/get/ieee?submissionId=5582", "http://ciberindex.com/index.php/ev/citationstylelanguage/get/modern-language-association?submissionId=5582", "http://ciberindex.com/index.php/ev/citationstylelanguage/get/turabian-fullnote-bibliography?submissionId=5582", "http://ciberindex.com/index.php/ev/citationstylelanguage/get/vancouver?submissionId=5582", "http://ciberindex.com/index.php/ev/citationstylelanguage/download/ris?submissionId=5582", "http://ciberindex.com/index.php/ev/citationstylelanguage/download/bibtex?submissionId=5582", "http://ciberindex.com/index.php/ev/issue/view/294", null, "https://twitter.com/share", "#com", "#com", "javascript:na_open_window('win','/comentarios/nu.htm',0,0,600,400,0,0,0,1,0);", "http://fundacionindex.com/", "http://fundacionindex.com/?page_id=371", "http://cuiden.fundacionindex.com/cuiden/", "http://campus.findexuniversidad.com/", "http://fundacionindex.com/?page_id=1053", "http://www.fundacionindex.com/blog_oebe/?page_id=5", "http://www.index-f.com/hemeroteca.php", "http://fundacionindex.com/?page_id=462", "http://www.fundacionindex.com/blog/", "http://ciberindex.com/index.php/proT", "http://www.index-f.com/casamagina/inicio.php", "http://fundacionindex.com/?page_id=1053", "http://fundacionindex.com/?page_id=1053", "http://www.fundacionindex.com/catedra/master-epa-ostomias/", "mailto:secretaria@ciberindex.com"]}